GlassScriptPhysician profile
Elizabeth H Hamilton
NPI 1699745570
$2,902.87
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $891 · 2020: $793 · 2021: $669 · 2022: $492 · 2023: $57.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $57.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $57.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $592.15 | 2019-2023 | |
| Pfizer INC. | $295.82 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $220.62 | 2019-2020 | |
| Janssen Biotech, INC. | $220.45 | 2019-2022 | |
| Leo Pharma INC. | $191.96 | 2019-2021 | |
| Genzyme Corporation | $183.06 | 2019-2022 | |
| Almirall LLC | $141.63 | 2019-2022 | |
| Galderma Laboratories, L.P. | $137.07 | 2019-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $135.57 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $110.09 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $73.23 | 2021-2022 | |
| Amgen INC. | $64.96 | 2021 | |
| Sensus Healthcare, INC. | $62.43 | 2019 | |
| Celgene Corporation | $60.71 | 2019 | |
| Lilly USA, LLC | $52.93 | 2019-2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $52.74 | 2022 | |
| Vyne Pharmaceuticals INC. | $49.31 | 2020 | |
| Epi Health, LLC | $48.26 | 2020-2021 | |
| Biofrontera INC. | $44.85 | 2019-2022 | |
| Aclaris Therapeutics, INC. | $41.17 | 2019 | |
| Sanofi-Aventis U.S. LLC | $34.19 | 2020 | |
| Mayne Pharma Commercial LLC | $32.46 | 2019-2020 | |
| Ucb, INC. | $20.93 | 2019 | |
| Mission Pharmacal Company | $18.49 | 2019 | |
| Dermira, INC. | $17.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Hamilton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.